🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will compare the safety and effectiveness of two drugs-methotrex...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2000-02
Trial ID
NCT00004567
Treatments Being Tested
This retrospective study aims to assess the effectiveness of systemic treat...
Status
Completed
Location
Erasmus MC
Start Date
2022-09-23
Trial ID
NCT06512766
Treatments Being Tested
This study is a prospective evaluation of systemic, intravenous high-dose m...
Status
Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2015-05
Trial ID
NCT02422641
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
Central nervous system (CNS) relapses of aggressive lymphomas are a rare bu...
Status
Unknown
Location
Charité Universitätsmedizin
Start Date
2007-10
Trial ID
NCT01148173
Treatments Being Tested
The objectives of this prospective non-interventional study are to characte...
Status
Recruiting
Location
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Start Date
2025-11-17
Trial ID
NCT07290803
Methotrexate (MTX), a folic acid analogue, inhibits the synthesis of purine...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-01
Trial ID
NCT06872073
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929...
Status
Active Not Recruiting
Location
Cancer Clinic
Start Date
2019-05-09
Trial ID
NCT03769506
Treatments Being Tested
This is a Phase IIIb/IV, open label, multicentre study of efalizumab (anti ...
Status
Completed
Location
Medical Information
Start Date
2004-12-13
Trial ID
NCT00249808
Treatments Being Tested
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested